83 related articles for article (PubMed ID: 9753617)
1. Reduced susceptibility of electroporated tumor cell lines to killing by cytotoxic lymphocytes.
Dressel R; Baraki H; Langer F; Günther E
Biochem Biophys Res Commun; 1998 Sep; 250(2):259-63. PubMed ID: 9753617
[TBL] [Abstract][Full Text] [Related]
2. Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.
Möller P; Möller H; Sun Y; Dorbic T; Henz BM; Wittig B; Schadendorf D
Cancer Gene Ther; 2000 Jul; 7(7):976-84. PubMed ID: 10917199
[TBL] [Abstract][Full Text] [Related]
3. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
4. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
5. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
6. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
7. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Falk CS; Noessner E; Weiss EH; Schendel DJ
Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
9. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y
Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578
[TBL] [Abstract][Full Text] [Related]
10. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.
Garnett CT; Palena C; Chakraborty M; Tsang KY; Schlom J; Hodge JW
Cancer Res; 2004 Nov; 64(21):7985-94. PubMed ID: 15520206
[TBL] [Abstract][Full Text] [Related]
11. Induction of antitumor response by in vivo allogeneic major histocompatibility complex gene transfer using electroporation.
Shimizu H; Nukui Y; Mitsuhashi N; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Miyazaki M
J Surg Res; 2009 Jun; 154(1):60-7. PubMed ID: 19101693
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
13. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
Chan RC; Xie Y
Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
[TBL] [Abstract][Full Text] [Related]
14. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
Faraoni I; Cottarelli A; Giuliani A; Bonmassar L; Rossi L; Bonmassar E
J Immunol Methods; 2005 Oct; 305(2):162-72. PubMed ID: 16165149
[TBL] [Abstract][Full Text] [Related]
15. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
Winter H; Hu HM; Urba WJ; Fox BA
J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogens affect both pathways of killer cell-mediated oncolysis.
Haeryfar SM; Nagy E; Baral E; Krepart G; Lotocki R; Berczi I
Anticancer Res; 2000; 20(3A):1849-53. PubMed ID: 10928117
[TBL] [Abstract][Full Text] [Related]
17. Immunization with truncated sequence of Telomerase Reverse Transcriptase induces a specific antitumor response in vivo.
Qiu J; Li GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W
Acta Oncol; 2007; 46(7):961-8. PubMed ID: 17917827
[TBL] [Abstract][Full Text] [Related]
18. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
19. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
[TBL] [Abstract][Full Text] [Related]
20. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
